Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-10-04

Clinical Trial Update: Role of Cytochrome P450 2D6 (CYP2D6) *4 Polymorphism,in Malignant Breast Diseases

View source ↗

Summary

A completed study from Mansoura University examining the influence of the CYP2D6*4 polymorphism on malignant breast diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mansoura University | Conditions: Breast Cancer | Status: COMPLETED